HP may bump Oracle in software for verticals

Speculation abounds concerning the direction Hewlett-Packard will take under new CEO Léo Apotheker. Some analysts foresee the tech giant on an Oracle-like path, pursuing such vertical markets as life sciences or healthcare. Oracle's acquisitions of EDC/CTMS provider Phase Forward and drug safety and risk management software maker Relsys are examples of the company's tactics along these lines.

HP realized just 3 percent of its 2010 revenue from software, which Apotheker sees as fertile ground, says IDG News Service. He envisions acquisitions and internal investments driving a doubling or tripling of software revenues. An initial target is business intelligence, another Oracle priority.

Yet another possibility for HP's direction, from the analyst perspective, is a strategy involving collaborative, agile business networks, which prior to joining HP Apotheker called "the next big thing." He described the goal of such collaborations as optimizing inter-company processes rather than processes within a company.

- see the article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.